Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company
29. November 2017 07:00 ET
|
Melinta Therapeutics
- Acquisition positions Melinta as durable and focused pure-play antibiotics company with four marketed products: Baxdela®, Vabomere®, Orbactiv®, and Minocin IV® - - Peak sales potential of the...
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
30. November 2015 10:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
09. November 2015 16:43 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...